royal medical semaglutide MHRA approves to prevent cardiovascular events in overweight and obese adults Oral Semaglutide Gets FDA Approval

doi:10.1056/NEJMoa1607141 Gerstein HC, Colhoun HM, Dagenais GR, et al

New medicines that mimic a natural gut hormone called GLP-1 have already changed how clinicians treat type 2 diabetes, obesity and related cardiometabolic consequences

Berutti talk more about Dynamic Life Health Centers approach to functional medicine

on Wednesday to watch Ozempic Underworld: The Black Market of Obesity Drugs

For Lean Muscle and Body Composition Beyond Belly Fat For patients whose goals extend beyond visceral fat to lean muscle preservation, recovery, and overall body composition, the modern approach is often to layer Tesamorelin with CJC-1295/Ipamorelin rather than choosing between Tesamorelin and Sermorelin